Physician profile
Thomas E Dukovac
NPI 1548641061
$1,186.10
in general payments reported to CMS, 2019-2025
22 companies · $197 in 2025
The $197 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $126 · 2021: $32.20 · 2022: $270 · 2023: $234 · 2024: $327 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $758.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $174.69 | 2020-2023 | Rezum Generator |
| Cook Medical LLC | $167.23 | 2022-2024 | Cook, Litho 150 |
| Astellas Pharma US INC | $92.77 | 2022-2024 | Xtandi |
| Progenics Pharmaceuticals, INC. | $80.47 | 2023-2024 | Pylarify |
| Coloplast Corp | $63.24 | 2022-2025 | Altis |
| Pfizer INC. | $55.63 | 2022-2023 | |
| Olympus America INC. | $54.24 | 2021-2024 | Itind System |
| Laborie Medical Technologies Corp. | $52.41 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Ferring Pharmaceuticals INC. | $44.93 | 2024-2025 | Adstiladrin |
| Tolmar, INC. | $44.45 | 2023-2024 | |
| Photocure INC | $44.34 | 2023-2024 | Cysview |
| Innovation Technologies INC | $43.93 | 2025 | Irrisept |
| Sumitomo Pharma America, INC. | $39.84 | 2023-2025 | Orgovyx |
| Dendreon Pharmaceuticals LLC | $39.72 | 2025 | Provenge |
| Axonics, INC. | $36.20 | 2023-2024 | Axonics |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $32.08 | 2025 | Cios Alpha |
| Sobi, INC | $30.19 | 2021-2022 | |
| Procept Biorobotics Corporation | $21.20 | 2024 | Aquabeam System |
| Abbvie INC. | $18.53 | 2024 | |
| Urogen Pharma, INC. | $18.02 | 2022 | |
| Janssen Biotech, INC. | $17.59 | 2024 | Erleada |
| Smith+Nephew, INC. | $14.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Dukovac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.